Lexeo Therapeutics, Inc. LXEO
- LX2020 — Arrhythmogenic Cardiomyopathy Phase 1
PKP2 (2 companies · 2 programs)
Companies with an active program directed at PKP2.
ROCKET PHARMACEUTICALS, INC. RCKT
- RP-A601 — Arrhythmogenic Cardiomyopathy Phase 1
Companies with an active program directed at PKP2.